Yissum, the technology transfer office of Hebrew University of Jerusalem, has signed an exclusive license and collaboration agreement with PhytoTech Medical on a delivery system aimed at medical cannabis.
The two will work together on the development, manufacturing, and marketing of a delivery system which will enhance the bioavailability of cannabidiol (CBD) and tetrahydrocannabinol (THC) – the two active ingredients in cannabis.
The move comes after PhytoTech became the first medical cannabis company to flout on the Australian Securities Exchange…
